Back
53
95
79
63
27
51
Day Range
$14.29
$14.84
52-Week Range
$6.83
$16.54
Volume
857,134
50D / 200D Avg
$14.57
/
$12.72
Prev Close
$14.21
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (627 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 6.7 | 0.3 |
| P/B | 3.3 | 3.0 |
| ROE % | 59.9 | 3.7 |
| Net Margin % | 101.5 | 3.8 |
| Rev Growth 5Y % | 57.8 | 10.0 |
| D/E | 0.1 | 0.2 |
Analyst Price Target
Hold
$15.50
+7.9%
Low: $15.00
High: $16.00
Forward P/E
17.67
Forward EPS
$0.81
EPS Growth (est.)
+0.0%
Est. Revenue
326.22M
Earnings Estimates
| Period | EPS Est. | Revenue Est. | Analysts |
|---|---|---|---|
| FY2030 |
$1.64
$1.56 – $1.84
|
517.12M | 2 |
| FY2029 |
$1.26
$1.19 – $1.41
|
466.27M | 2 |
| FY2028 |
$1.27
$0.43 – $2.12
|
443.41M | 4 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2026-02-26 | $0.22 | $0.26 | +20.0% |
| 2025-11-04 | $0.16 | $0.23 | +43.8% |
| 2025-07-31 | $0.17 | $0.16 | -5.9% |
| 2025-05-12 | $0.08 | $0.16 | +100.0% |
| 2025-02-27 | $0.03 | $0.09 | +200.0% |
| 2024-11-07 | $0.02 | $0.10 | +566.7% |
| 2024-08-01 | $0.02 | $0.02 | +20.0% |
| 2024-05-02 | -$0.17 | -$0.03 | +82.4% |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 57.84% annually over 5 years — strong growth
Earnings grew 4893.08% over the past year
ROE of 59.91% indicates high profitability
Net margin of 101.47% shows strong profitability
Debt/Equity of 0.13 — conservative balance sheet
Generating 135.41M in free cash flow
Growth
Revenue Growth (5Y)
57.84%
Revenue (1Y)20.38%
Earnings (1Y)4893.08%
FCF Growth (3Y)N/A
Quality
Return on Equity
59.91%
ROIC11.99%
Net Margin101.47%
Op. Margin37.06%
Safety
Debt / Equity
0.13
Current Ratio5.25
Interest Coverage24.23
Valuation
P/E Ratio
6.65
Forward P/E17.90
P/B Ratio3.29
EV/EBITDA18.16
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 20.38% | Revenue Growth (3Y) | 26.99% |
| Earnings Growth (1Y) | 4893.08% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 57.84% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 283.06M | Net Income (TTM) | 287.20M |
| ROE | 59.91% | ROA | 38.21% |
| Gross Margin | 88.46% | Operating Margin | 37.06% |
| Net Margin | 101.47% | Free Cash Flow (TTM) | 135.41M |
| ROIC | 11.99% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.13 | Current Ratio | 5.25 |
| Interest Coverage | 24.23 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 6.65 | Forward P/E | 17.90 |
| P/B Ratio | 3.29 | P/S Ratio | 6.75 |
| PEG Ratio | 0.00 | Forward PEG | N/A |
| EV/EBITDA | 18.16 | Fwd EV/EBITDA | N/A |
| Forward P/S | 5.86 | Fwd Earnings Yield | 5.59% |
| FCF Yield | 7.09% | ||
| Market Cap | 1.91B | Enterprise Value | 1.91B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 283.06M | 235.13M | 175.51M | 134.03M | 45.61M |
| Net Income | 287.20M | 5.75M | -78.02M | -108.18M | -180.97M |
| EPS (Diluted) | 2.07 | 0.04 | -0.54 | -0.76 | -1.40 |
| Gross Profit | 250.39M | 206.89M | 161.37M | 128.37M | 44.51M |
| Operating Income | 104.91M | -4.69M | -91.69M | -111.47M | -180.74M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 751.59M | 550.65M | 548.06M | 470.86M | 543.37M |
| Total Liabilities | 170.26M | 173.17M | 170.11M | 65.43M | 64.28M |
| Shareholders' Equity | 581.33M | 377.48M | 377.95M | 405.44M | 479.09M |
| Total Debt | 74.81M | 79.37M | 97.61M | 8.09M | 8.74M |
| Cash & Equivalents | 80.21M | 83.43M | 48.88M | 94.17M | 231.90M |
| Current Assets | 491.97M | 446.60M | 424.80M | 442.54M | 513.32M |
| Current Liabilities | 93.72M | 97.76M | 77.19M | 46.11M | 40.65M |
Strategy Scores
This stock passed the criteria for 6 strategies
Score = fit strength (0–100)
Rank = position among all matches
Custom
Capital Light Compounder
#50 of 218
#5 of 670
#30 of 157
#6 of 203
Custom
Full Throttle
#127 of 146
Custom
Lower Risk
#40 of 140
Recent Activity
Entered
Capital Light Compounder
Mar 24, 2026
Entered
Contrarian Investing (David Dreman)
Mar 24, 2026
Entered
Growth Investing (Philip Fisher)
Mar 24, 2026
Entered
Value Investing (Warren Buffett)
Mar 24, 2026
Entered
Full Throttle
Mar 24, 2026
Entered
Lower Risk
Mar 24, 2026